omeprazole capsule, delayed release
dr. reddy's laboratories limited - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole 10 mg - omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence. triple therapy omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults. dual therapy omeprazole delayed-release capsules in combination with clarithromycin are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults. among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin are more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. in patients who fail therapy, susce
omeprazole capsule, delayed release
redpharm drug, inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole 20 mg - 1.1 treatment of active duodenal ulcer omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy. 1.2 helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence. triple therapy omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults. dual therapy omeprazole delayed-release capsules in combination with clarithromycin are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults. among patients who fail therapy, omeprazole delayed-release capsules are with clarithromycin is more likely to be associated wit
esomeprazole 20mg gastro-resistant capsules
a a h pharmaceuticals ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg
esomeprazole 20mg gastro-resistant capsules
alliance healthcare (distribution) ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg
esomeprazole 20mg gastro-resistant capsules
waymade healthcare plc - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg
esomeprazole 20mg gastro-resistant capsules
de pharmaceuticals - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg
esomeprazole 20mg gastro-resistant capsules
actavis uk ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg
esomeprazole 20mg gastro-resistant capsules
sigma pharmaceuticals plc - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg
esomeprazole 20mg gastro-resistant capsules
mawdsley-brooks & company ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg
esomeprazole 20mg gastro-resistant capsules
aristo pharma ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg